The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

BACKGROUND: The clinical trials using immunotherapy have been performed for the treatment of variety of malignant tumors. However, large-scale meta-analysis of combined DC-CTL/CIK therapy on immune and clinical response in patients has not been well studied yet. The purpose of this study is to inves...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Exp Hematol Oncol
Prif Awduron: Wang, Ying, Xu, Zenghui, Zhou, Fuping, Sun, Yan, Chen, Jingbo, Li, Linfang, Jin, Huajun, Qian, Qijun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2015
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641330/
https://ncbi.nlm.nih.gov/pubmed/26561538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-015-0027-9
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg